Document is current
Any future updates will be listed below
-
Authors
Galli, Mattia
Angiolillo, Dominick J. https://orcid.org/0000-0001-8451-2131
- License Information
-
More Information
Article History
Received: 19 November 2025
Accepted: 21 November 2025
First Online: 2 December 2025
Declarations
:
: Dr Galli declares that he has received consulting fees from Werfen and Genomadix; He is the PI of the following active grant: Sapienza University of Rome (Grant protocol n. RG1241910F5A1A50). Dr Angiolillo has received consulting fees or honoraria from Abbott, Amgen, Anthos, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, CSL Behring, Daiichi-Sankyo, Eli Lilly, Faraday, Haemonetics, Janssen, Merck, Novartis, Novo Nordisk, PhaseBio, PLx Pharma, Pfizer, Sanofi, Viatris and Werfen; and his institution has received research grants from Amgen, AstraZeneca, Bayer, Bio-sensors, CeloNova, Daiichi-Sankyo, Eisai, Eli Lilly, Faraday, Gilead, Idorsia, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, and the Scott R. MacKenzie Foundation.
Free to read: This content has been made available to all.
